[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-MNPR":3,"homepage-market-summary":31,"stock-news-MNPR":174},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"MNPR","2026-10-06",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Monopar Therapeutics Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company developing a treatment for Wilson disease and novel radiopharmaceuticals for oncology. Its Wilson disease product candidate is ALXN1840, a late-stage, investigational once-daily, oral medicine. The group radiopharmaceutical programs consist of Phase 1-stage MNPR-101-Zr for imaging cancers, and Phase 1a-stage MNPR-101-Lu and late preclinical-stage MNPR-101-Ac for the treatment of cancers that express urokinase plasminogen activator receptor (uPAR). It build drug development pipeline through both in-house efforts and licensing of late preclinical- and clinical-stage therapeutics. The Company operates as a single reportable segment, focusing on the development of clinical and preclinical product candidates.","22","Wilmette, IL",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},79.57,78.04,82.66,75.325,78.29,1.28,1.63,301956.695092,5714,78.5522,124.82,50.07,202945.96253788445,39.5,1706,{"status":32,"indices":33,"watchlist":77,"sectors":99,"benchmarks":155},"success",[34,42,49,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7818.93,44.98,0.58,true,"0.0,11.6 2.3,13.9 4.6,10.5 6.9,12.4 9.3,14.2 11.6,16.0 13.9,11.5 16.2,10.8 18.5,4.8 20.8,4.8 23.2,7.9 25.5,8.0 27.8,6.0 30.1,9.1 32.4,9.8 34.7,10.8 37.1,10.0 39.4,7.0 41.7,4.4 44.0,2.0",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",31224.47,148.03,0.48,"0.0,13.0 2.3,15.0 4.6,13.4 6.9,14.8 9.3,16.0 11.6,16.0 13.9,12.9 16.2,11.7 18.5,6.5 20.8,5.0 23.2,6.6 25.5,6.6 27.8,5.8 30.1,7.8 32.4,7.4 34.7,7.0 37.1,6.4 39.4,4.6 41.7,2.9 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51521,253,0.49,"0.0,3.6 2.3,6.3 4.6,2.0 6.9,3.3 9.3,6.0 11.6,11.3 13.9,8.7 16.2,9.5 18.5,6.4 20.8,8.0 23.2,10.9 25.5,12.3 27.8,8.2 30.1,11.2 32.4,12.3 34.7,16.0 37.1,15.8 39.4,13.7 41.7,13.0 44.0,10.8",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27599.79,122.48,0.45,"0.0,13.6 2.3,15.1 4.6,12.9 6.9,14.2 9.3,16.0 11.6,16.0 13.9,12.2 16.2,11.3 18.5,6.1 20.8,5.1 23.2,7.7 25.5,7.7 27.8,6.6 30.1,8.7 32.4,8.9 34.7,8.4 37.1,8.3 39.4,5.5 41.7,3.1 44.0,2.0",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":14,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2813.4,-20.4,-0.72,"0.0,2.0 2.3,5.2 4.6,3.9 6.9,5.8 9.3,8.0 11.6,9.4 13.9,7.7 16.2,9.2 18.5,7.6 20.8,5.8 23.2,11.6 25.5,11.9 27.8,11.5 30.1,13.7 32.4,14.8 34.7,16.0 37.1,14.8 39.4,12.0 41.7,10.0 44.0,12.2",{"symbol":71,"name":72,"price":73,"change":74,"pct_change":75,"is_up":14,"sparkline":76,"date":5},"VIX","CBOE VIX",15.01,-0.51,-3.29,"0.0,7.3 2.3,2.0 4.6,9.7 6.9,4.9 9.3,4.5 11.6,2.5 13.9,11.3 16.2,13.7 18.5,13.5 20.8,16.0 23.2,12.3 25.5,10.4 27.8,13.5 30.1,8.8 32.4,8.9 34.7,7.8 37.1,7.6 39.4,11.8 41.7,10.9 44.0,12.9",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":40,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",239.24,0.34,0.14,"0.0,14.1 7.3,16.0 14.7,14.6 22.0,11.8 29.3,8.2 36.7,2.4 44.0,2.0",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":40,"sparkline":91,"date":5},"AAPL","Apple Inc",333.63,0.74,0.22,"0.0,2.0 7.3,16.0 14.7,10.4 22.0,14.6 29.3,9.3 36.7,10.6 44.0,9.4",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":40,"sparkline":98,"date":5},"TSLA","Tesla Inc",380.68,1.95,0.51,"0.0,13.7 7.3,16.0 14.7,15.0 22.0,15.4 29.3,7.1 36.7,3.0 44.0,2.0",[100,105,110,115,120,125,130,135,140,145,150],{"name":101,"etf":102,"change":103,"price":104,"is_up":40},"Technology","XLK",0.53,202,{"name":106,"etf":107,"change":108,"price":109,"is_up":40},"Financials","XLF",0.24,54.01,{"name":111,"etf":112,"change":113,"price":114,"is_up":14},"Healthcare","XLV",-0.17,167.09,{"name":116,"etf":117,"change":118,"price":119,"is_up":40},"Consumer Cycl","XLY",1.2,111.75,{"name":121,"etf":122,"change":123,"price":124,"is_up":40},"Consumer Staples","XLP",0.9,81.77,{"name":126,"etf":127,"change":128,"price":129,"is_up":40},"Energy","XLE",0.47,63.75,{"name":131,"etf":132,"change":133,"price":134,"is_up":40},"Industrials","XLI",0.87,171.58,{"name":136,"etf":137,"change":138,"price":139,"is_up":40},"Materials","XLB",0.46,49.73,{"name":141,"etf":142,"change":143,"price":144,"is_up":40},"Real Estate","XLRE",1.06,41.1,{"name":146,"etf":147,"change":148,"price":149,"is_up":40},"Utilities","XLU",2.98,41.16,{"name":151,"etf":152,"change":153,"price":154,"is_up":40},"Comm Services","XLC",0.04,111.65,[156,161,165,169],{"ticker":157,"name":158,"price":159,"change":160,"is_up":40},"SPY","SPDR S&P 500 ETF",779.09,0.55,{"ticker":162,"name":163,"price":164,"change":138,"is_up":40},"QQQ","Invesco QQQ Trust",759.69,{"ticker":166,"name":167,"price":168,"change":47,"is_up":40},"DIA","SPDR Dow Jones ETF",514.56,{"ticker":170,"name":171,"price":172,"change":173,"is_up":14},"IWM","iShares Russell 2000",281.37,-0.71,{"ticker":4,"count":175,"articles":176},16,[177,183,189,194,200,206,211,217,223,228,233,238,243,248,253,259],{"title":178,"link":179,"pubDate":180,"description":181,"source":182},"After a $0.005-per-share option exercise, Monopar Therapeutics (MNPR) director sells 8,400 shares. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitAFBVV95cUxQNjB3MVBRdER4dHJKc1RMTmEzQzd2UXBWeGFRaDE0UE9LWjQ4TTVOMGZDX3pScHpPd0xiaWZOc2NSMHdRenVrcFdCWU55ai0zUmFUaW5fZkhUajRRVGlkVGgwREplYVY3UzZHaUwtem5tcFRLMlBnQzlkRHZVb3VIWmhIalJjZldQV2hJWUZHdXBFT3o3cmpwd1hjaFVlMGZDalRDUTJIV3FLazRTZzh4ZXFjVmk?oc=5","Mon, 05 Oct 2026 21:43:55 GMT","After a $0.005-per-share option exercise, Monopar Therapeutics (MNPR) director sells 8,400 shares. Stock Titan","Stock Titan",{"title":184,"link":185,"pubDate":186,"description":187,"source":188},"Responsive Playbooks and the MNPR Inflection - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwgFBVV95cUxQemllNl9nTnJ3eFM0LTlPNDYyTDZaYXlYTkhNU2F4STdlSWg3SnFLdVV1MWh4ZEF1NWFSWTdmVUFBU19DZHJTdy04bnJpQS0wSW83Nl95NjhSOHRuNXY5d3lEaHc2Y2VNV2V5dEJKUHpVOF9WcFdhTHJwVFlINXZSLWtTR2pDM0MxbXNyaW91cC1rTEJIMkZIY0RqdnUtT2JtUlc2aVlfM2JWYUV1NUFiRWI3My1xM3loRS1LeS16M191QQ?oc=5","Tue, 06 Oct 2026 21:48:01 GMT","Responsive Playbooks and the MNPR Inflection Stock Traders Daily","Stock Traders Daily",{"title":190,"link":191,"pubDate":192,"description":193,"source":182},"Stock-option shares are proposed for sale by Chandler Robinson at Monopar Therapeutics (NASDAQ: MNPR). - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMingFBVV95cUxPU3lXd2dDQWl1Zms4ZFlsRVpyUUQyd0o0LWxKWlpQZFdfNGNCd0FBelR3bi1vcWxVRFcxUldXZ0dfSGY0NDdCUnB6eERCMUVzMEZ2Y2RSSk5MY1JDX0ZvejNxLUNJdHFVMDBYeWhTczVvS1FwWTVNdXZVREluMFZScTJad2Y5QTZ1bkNBdHJpbFdPY19nUHhxNm90LUNXZw?oc=5","Thu, 24 Sep 2026 07:00:00 GMT","Stock-option shares are proposed for sale by Chandler Robinson at Monopar Therapeutics (NASDAQ: MNPR). Stock Titan",{"title":195,"link":196,"pubDate":197,"description":198,"source":199},"Monopar Therapeutics CEO Robinson sells $2.5m in stock - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxObDh4cEhNSWcxemxMcmhIYUQ0QVpaa0ZtS2x6Z0JZc3B4bjU0dDZvb2lxMEFqcmFPdzYwWGhMVmNRaXNEV0hqbnAwNlZOcGpLZnRYSWV4N3NCUkhNVGhlcFBxVHNWaXI5R2ZrWExIeUYzUlEwWGJtS2xDR2ZpZTdwQkp3T21iMzVndHVXRGttS2dpbVVUM1hSTlJEWGRoYVNkSnRBSXVCQUhOd1FrTVY2ZE1tZDhQOGpf?oc=5","Tue, 29 Sep 2026 02:03:52 GMT","Monopar Therapeutics CEO Robinson sells $2.5m in stock Investing.com","Investing.com",{"title":201,"link":202,"pubDate":203,"description":204,"source":205},"Monopar Therapeutics stock trades on a clinical pipeline catalyst - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwgFBVV95cUxQRHBNaHBLSG50LWo2QjFXam5tTVV6NnhCZ2dfSkluYmxCVDE4NlZ4WE9lSDlaQ3c2WVpoVlM0NGRYSWNDeE1WNUotbVFYbDFmN0NmbFhCNnBGTTI3QjRUUmh5SGJxemc2VzdvUS1JbkVTbnVJUll3VkVucEkzcjk2TGsya29tcWlIS0NnY3c5aTlHc1VpSElrMmx5cWY0Uzlqd0p6TC0xclQ2VjdyTW1ISHlwcHk4a2pIYVhDV1ZvelBmUQ?oc=5","Wed, 23 Sep 2026 13:21:03 GMT","Monopar Therapeutics stock trades on a clinical pipeline catalyst AD HOC NEWS","AD HOC NEWS",{"title":207,"link":208,"pubDate":209,"description":210,"source":182},"16,800 shares are proposed for sale by Monopar Therapeutics (MNPR) director Christopher Starr. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMingFBVV95cUxPQkIyMTFBdHdmQkw3QkZNVmpsTkZpOTlmZjh1R0dLc1VaNVJWcHFVeVBCTTFQUmFHYWtmTzM3ZDRlMHcyNF9xb19FTjhPWEFaREFKREFHckJBd1ZFYlg0ZzFtRU1uT3ZQSjNxT2trOWU4VWl6ZUhBb1d2enlDd1pvQWRjV1J1RW5LdUd5OWZuaGFSRzlHM0VNclFzaWRrdw?oc=5","Thu, 01 Oct 2026 20:38:00 GMT","16,800 shares are proposed for sale by Monopar Therapeutics (MNPR) director Christopher Starr. Stock Titan",{"title":212,"link":213,"pubDate":214,"description":215,"source":216},"MNPR Q2 2026 Earnings: Narrower-Than-Expected Loss, Yet Shares Slide - Long-Term Guidance - https:\u002F\u002Fwww.siam.in\u002F","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqwFBVV95cUxOWS1pdkhWS1Z5SW42alpBdDlKNWV1bTMyUVkteXpXZV9Xek5KQWc1ZjMzSlQwbC1hQmFJOXItMzVCa1QyRWFMY3c5cEg3NDNYRHNobVBOQl9qSzJGTzdzeTRqdmJ6QlVMVGVicUIyNVJ1czhOYWRxWlNDWmxpZmRaNm5NeVJPekp1S0FWVV9OY055b1RKcUhJUDc2QmtJWEg3UnBBUF9aT1dUUWc?oc=5","Tue, 29 Sep 2026 18:40:23 GMT","MNPR Q2 2026 Earnings: Narrower-Than-Expected Loss, Yet Shares Slide - Long-Term Guidance https:\u002F\u002Fwww.siam.in\u002F","https:\u002F\u002Fwww.siam.in\u002F",{"title":218,"link":219,"pubDate":220,"description":221,"source":222},"Monopar Therapeutics director Starr sells $659,386 in stock By Investing.com - Investing.com UK","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiugFBVV95cUxQdzNZRW1vVnBUOUM3cDdBRGV3elRNVXY5NkpLbXJOU2pjMGtxNE44RDZmd2JoZ3VkNlNOZmVPamhqUHAzdUV3TUhKM2NBWEUyQ2FhWHZlaG1oM3lvNjhUak1PYkJtZFJfWXdJUS0zZkxLT1pfb1dNSmRBVmM3QmVvNDZMVElJYU4wMGdzcVlaSkdYLWtfeDJDeXJmY3luUk95dFRQVEwwRmk0X1JybHFPbzI5alhQeW1Camc?oc=5","Tue, 06 Oct 2026 11:48:00 GMT","Monopar Therapeutics director Starr sells $659,386 in stock By Investing.com Investing.com UK","Investing.com UK",{"title":224,"link":225,"pubDate":226,"description":227,"source":205},"Monopar Therapeutics stock faces insider selling after Q2 loss - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxPRE55YnQxM1BUbERabVpiYkZLUDBlSDNKZXY0VHlWR1R3VXZGTTE5Zk1LYkVNZGRjbW5vWjM5eXlLQy11bjhpS2lCdjc4a2M2eTdYN21DUG1aYkxaVGZsN3B4Y2FWUDNIUkM5VURQcVFMUlJzZ0paVTNGWkZicDdnVGx1NDYwT2xUOVhIRU5tS2FwTERTUmp1czRvX1BzbHZja1hpNDYwcUVrTkpWdEM4Y09RbmwzWmVqNFZ5OXF3?oc=5","Wed, 07 Oct 2026 03:46:02 GMT","Monopar Therapeutics stock faces insider selling after Q2 loss AD HOC NEWS",{"title":229,"link":230,"pubDate":231,"description":232,"source":182},"For withholding tax, Monopar Therapeutics (MNPR) withholds 1,944 shares from its COO. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitAFBVV95cUxOMmlCcnoyWXlNZzNxQnVlQ09BOVU5eUt0UlJhVkhtbTRCQ3l3QkFmS2ZpMTVEZklCSkNZTzhodGxycnp6V0NHWU8tbzNFTTM3TzdpbXptNVRpTHhUNVlwTmhwRWQwcWZQUDQzVnVnb3A0THRtbUxQdDN3V0VTM2Q0QjRuRVJsY25YMTlWb3U4OUU0NHNvYU1SVWotQjY2QzdtMXprTkNKbHdKbm9oQWl4Qkp0Z24?oc=5","Fri, 02 Oct 2026 22:15:34 GMT","For withholding tax, Monopar Therapeutics (MNPR) withholds 1,944 shares from its COO. Stock Titan",{"title":234,"link":235,"pubDate":236,"description":237,"source":182},"4,344 CEO shares were withheld for taxes by Monopar Therapeutics (MNPR). - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitAFBVV95cUxQQU1MQll0NkRaTDVTVVpzcnp4UU1GV05oMGdDUFZXQW9KR3g3QUh2WFdndl9NalFudzgwYjE1aXNKZVpjZXBPVTlFb1l6NUk1QjVQUS1HRmNkVFhGdUdWa1NCWWdUQS1fWkRkZWRPb0wzRlZXQW1weS1ZUlNPT3Eyek5veXRkMHl2RUlqQ1YzSndGOXQ5SE1VWndhX1lncy1GYVEwanJKWk5VZzlVaEZLN3hncE8?oc=5","Fri, 02 Oct 2026 22:15:10 GMT","4,344 CEO shares were withheld for taxes by Monopar Therapeutics (MNPR). Stock Titan",{"title":239,"link":240,"pubDate":241,"description":242,"source":205},"Monopar Therapeutics stock falls 7.5 percent on September 23 - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxNNnBBbnJDVXk0MU5BUXNZV0VYVzRuYmRYN1dZc2RaQktRcjJrLUhvX2JhUnVLNG4tTlBDZEJTVGxuVVRWUXBUQjJkZHltYmxXMUFhTGg2U2NEQzNsdXhvQ0pUZTJpQklITk9ZSDA1MXNxOGpmVUc2TmRnWHZBT3gxWGJPT2paaHQ3MWNEQXI5R2puUDJselhPbk90QmdOaG8zcGxMWTlnM0kyQUdFeThjLVJUaEo5WHh3UkpJ?oc=5","Wed, 23 Sep 2026 22:30:15 GMT","Monopar Therapeutics stock falls 7.5 percent on September 23 AD HOC NEWS",{"title":244,"link":245,"pubDate":246,"description":247,"source":182},"180 shares cover CFO taxes as Monopar Therapeutics (MNPR) settles a 614-share stock grant. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitAFBVV95cUxNOHBKVVVyMkNMQ3g5MW81SERpZmswYnFjVVlLYVVFVnBOU1hNWVlWVkptSFFid0FvTU5sX1BTc2VaVk15ZUFwVjNKZnM2aEh2ZWE0SlplLWJjSFZsLWY0OExUUlpxakhZSkt2N2Y3OTVYYzlRdlJ1RG9CSmpucjA3U1JJSEdtRW1uNU5pbmpOT1lvVE1XTGJicDE2bllTSnZQSzRRSXotdW1mai1SemFTREROVXU?oc=5","Fri, 02 Oct 2026 22:14:39 GMT","180 shares cover CFO taxes as Monopar Therapeutics (MNPR) settles a 614-share stock grant. Stock Titan",{"title":249,"link":250,"pubDate":251,"description":252,"source":182},"Four share sales at $87.15 to $89.79: Monopar Therapeutics (MNPR) CEO also exercised options. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitAFBVV95cUxOOFdwc1FXNE5Vd19ESmt5eVdfb0FxQWF0SW5QNWdiN0dlQXlmUGo1WUMzRVFBTUNiVHp1TTFZNW1fT0JVS3ZPS3RCLWxCRUdRV1hMRUtNcnNsWmJMOUZVRGtZX1g5ZEtHM3lDTU9jUVVrYkZQNVJ3U3ZHdkRSUkFiZW5rLTBjT3dBYVhFc2NOejZxN2hodlhNMzZiaE01a1l5RUItNWtmUWNpZVgyMlV0WS12Z0c?oc=5","Tue, 29 Sep 2026 01:00:32 GMT","Four share sales at $87.15 to $89.79: Monopar Therapeutics (MNPR) CEO also exercised options. Stock Titan",{"title":254,"link":255,"pubDate":256,"description":257,"source":258},"MNPR rises as buyers remain active during intraday volatility - Traders Union","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimwFBVV95cUxOMVNsakdUbW1OTlJhLUM2TmdJSTZ1WEdNNkdUeUI4UFdFV2I3Z2lTVjIxZkNoUERfZ1VFdk9pTzVTOXZUVlR1VHBjcDVUZE4yYXpYNll3U0x3dm5MTUJQUXhUaGZMcGpDTzFkTlI4Vy12cWhkOURuS2ZOZUN1QmZPb0pEeERTUUt2VDdsbUhjMmVEZ2hjOFhjZDNwQQ?oc=5","Tue, 06 Oct 2026 18:21:29 GMT","MNPR rises as buyers remain active during intraday volatility Traders Union","Traders Union",{"title":260,"link":261,"pubDate":262,"description":263,"source":258},"Form 4 insider transaction filed pressures Monopar Therapeutics stock below $74.23 support - Traders Union","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimwFBVV95cUxNaDJ4YktRZEl0R19HRXA1UWpMQXVPQ3Vydzg5MW9jM3o3cWp5LXJwVnkxMzREY25nLW1lcmpxVFpSejVGSS1nMHZZcG1qZ0V2MUZNTDZJTlh6aDdzZVV6RW41aDZaZmNOY0R1MUxFdW4xckxWMW9yRU1KZHhFalUxUS1WSGNOaFllNW5wWkNOY1B0UlVyYzFIY3lTZw?oc=5","Tue, 29 Sep 2026 15:41:37 GMT","Form 4 insider transaction filed pressures Monopar Therapeutics stock below $74.23 support Traders Union"]